Elaine Chang
Allogene Therapeutics Executive Director, Intellectual Property Counsel
Graduation year:
1996
Thesis:
Characterization of the Properties of HSV-1 U(L)31 and U(L)32 Gene Products
Advisor:
Bernard Roizman